Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03004976 · ClinicalTrials.gov registry record · Phase 2
Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke
A Phase 2 study, sponsored by Joanne Kurtzberg, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
NCT03004976 is a Phase 2 study that has completed, run by Joanne Kurtzberg, MD. The registered enrollment target is 79 participants.
The verdict
NCT03004976, a Phase 2 study, has completed, sponsored by Joanne Kurtzberg, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the efficacy of a single intravenous infusion of unrelated donor umbilical cord blood (UCB) for improving functional outcomes in patients with ischemic stroke. Eligible subjects will receive an intravenous infusion of UCB or placebo 3-10 days following stroke. Subjects will not receive immunosuppressive or myeloablative medications prior to the infusion. Subjects will be followed for one year post infusion for safety and efficacy. Assessments will examine safety and tolerability of the infusion, change in neurological symptoms, change in quality of life, and emotional and cognitive status. Assessments will occur at 24 hours post infusion, and at 30, 90, 180 and 365 days post infusion.
Interventions
- OTHER Placebo
- BIOLOGICAL Umbilical Cord Blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-03-14 |
| Est. Completion | 2021-03-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03004976
The ClinicalTrials.gov registry entry for NCT03004976 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joanne Kurtzberg, MD, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03004976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03004976 about?
NCT03004976 is a clinical study titled "Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke". The primary objective of this study is to determine the efficacy of a single intravenous infusion of unrelated donor umbilical cord blood (UCB) for improving functional outcomes in patients with ischemic stroke. Eligible subjects will receive an intravenous infusion of UCB or placebo 3-10 days follo...
What is the current status of trial NCT03004976?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2017-03-14. Estimated completion is 2021-03-27.
What interventions are being tested in trial NCT03004976?
The interventions under investigation include: Placebo (OTHER), Umbilical Cord Blood (BIOLOGICAL).
Who is sponsoring clinical trial NCT03004976?
This trial is sponsored by Joanne Kurtzberg, MD, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.